Skip to main content
Clinical Trials/CTRI/2024/04/065635
CTRI/2024/04/065635
Not yet recruiting
Phase 2

Bronchial Artery Embolization in the Management of Hemoptysis - NI

DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES JAWAHARLAL NEHRU MEDICAL COLLEGE0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: J398- Other specified diseases of upperrespiratory tractHealth Condition 2: J42- Unspecified chronic bronchitis
Sponsor
DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES JAWAHARLAL NEHRU MEDICAL COLLEGE
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES JAWAHARLAL NEHRU MEDICAL COLLEGE

Eligibility Criteria

Inclusion Criteria

  • 1\. The potential candidate for BAE is a patient meeting any of the following criteria:
  • 2\. Hemoptysis \>200ml /h or 600 ml /24 hrs
  • 3\. Hypovolemia due to acute Hemoptysis with systolic BP 90 mm hg.
  • 4\. Respiratory failure due to acute Hemoptysis requiring endotracheal intubation and mechanical
  • ventilation.

Exclusion Criteria

  • 1\. Patients not giving consent for the procedure.
  • 2\. Patients having deranged coagulation profile.
  • 3\. Patients declared unfit on pre\-anaesthetic checkups due to co\-morbidities
  • 4\. Pregnant patients.
  • 5\. Allergic to contrast media
  • 6\. Deranged KFT

Outcomes

Primary Outcomes

Not specified

Similar Trials